Triofan Rhume XyloMenthol 1mg/ml, spray nasal, solution

7680696970011 CH-69697 Spray

No image available

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Spray
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2026
Patient information leaflet
Français
01/05/2026
Patient information leaflet
Italien
01/05/2026
Summary of Product Characteristics
Allemand
01/05/2026
Summary of Product Characteristics
Français
01/05/2026
Summary of Product Characteristics
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
xylometazolini hydrochloridum
1.0 MG Substance Wirkstoff (Principe actif)
xylometazolini hydrochloridum
140.0 UG Substance Wirkstoff (Principe actif)
benzalkonii chloridum
0.1 MG Substance HBESI
dinatrii edetas
- Substance HNIDK
dinatrii phosphas dodecahydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
levomentholum
- Substance AROMA
cineolum
- Substance AROMA
macrogolglyceroli hydroxystearas
1.0 MG Substance HBESI
aqua purificata
- Substance HNIDK

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
69697
Drug name
Triofan Rhume XyloMenthol, spray nasal, solution
Galenic form
NASSL
ATC Code
R01AA07
Authorization status
Z
Dispensing category
D
First authorization
31/07/2025
Authorization expiration date
30/07/2030
IT Number
12.02.1.
Domain
Human medicine

Package details

Description (FR)
TRIOFAN Rhume XyloMenthol 1mg/ml nasal spray 1 mg
Description (DE)
TRIOFAN Rhume XyloMenthol 1mg/ml Nasenspray 1 mg 1
Market launch
03/09/2025
Market withdrawal
31/12/2099
Narcotic (BTM)
No
Buy us a coffee Explore the data